Building on over 45 years of experience with the extraction, purification and synthesis of high value intermediates and active pharmaceutical ingredients, BioVectra’s drug development activities focus on new chemical entities and generic products with complex active ingredients and challenging formulations.

Our team engages in product development in partnership with major pharmaceutical companies. Product selection capitalizes on our experience, expertise and capabilities, with specific focus on:

BioVectra’s drug development activities focus on new entity and generic products with challenging active ingredients and formulations with a particular interest in complex intravenous injectable and intramuscular sustained-release formulations. BioVectra has expertise in the use of lipid and polymer-based nanoparticulate formulations for solubilization, controlled release and targeting of drugs.

BioVectra’s labs are equipped with state-of-the-art equipment for physical and chemical characterization of APIs, excipients, nanoparticle preparation, and cGMP analytical testing. Specialized equipment includes microfluidizers, thermal analysis, and physicochemical characterization tools such as particle size, surface charge and surface area analyzers.

Formulation Capabilities include:

  • Nanoparticulate formulations (Lipid and Polymer based nanoparticles)
  • Depot formulations (PLGA based drug delivery systems)
  • Controlled release (IV and IM injectable formulations)
  • High potency API formulations (Taxanes)

BioVectra’s development and manufacturing expertise is extensive and includes:

  • Antibody drug conjugates

  • Potent compounds

  • Taxane chemistry

  • Liposomal formulations

  • MPEG chemistry and conjugation

  • Nanoparticles

  • Depot formulations

  • Many other product classes and formulation methods

We welcome inquiries for drug development partnership opportunities involving new chemical entities and generic pharmaceuticals.

Please contact us to learn more about our partnering opportunities.

Contact Us